vs
Astrana Health, Inc.（ASTH）与CrossAmerica Partners LP（CAPL）财务数据对比。点击上方公司名可切换其他公司
Astrana Health, Inc.的季度营收约是CrossAmerica Partners LP的1.1倍（$950.5M vs $866.3M），CrossAmerica Partners LP净利率更高（1.2% vs 0.7%，领先0.5%），Astrana Health, Inc.同比增速更快（42.9% vs -8.3%），CrossAmerica Partners LP自由现金流更多（$22.4M vs $-6.0M），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs -4.1%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
塔峰资本合伙人（TowerBrook Capital Partners）是一家总部位于伦敦和纽约的投资管理公司，2005年从索罗斯基金管理分拆独立。该机构主打私募股权及结构性机会投资，曾收购奢侈品品牌Jimmy Choo控股权，截至2025年其管理规模超250亿美元，官网公示在管投资项目共110个。
ASTH vs CAPL — 直观对比
营收规模更大
ASTH
是对方的1.1倍
$866.3M
营收增速更快
ASTH
高出51.1%
-8.3%
净利率更高
CAPL
高出0.5%
0.7%
自由现金流更多
CAPL
多$28.3M
$-6.0M
两年增速更快
ASTH
近两年复合增速
-4.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $866.3M |
| 净利润 | $6.6M | $10.2M |
| 毛利率 | — | 12.4% |
| 营业利润率 | 1.9% | 3.0% |
| 净利率 | 0.7% | 1.2% |
| 营收同比 | 42.9% | -8.3% |
| 净利润同比 | 184.4% | -39.6% |
| 每股收益（稀释后） | $0.12 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHCAPL
| Q4 25 | $950.5M | $866.3M | ||
| Q3 25 | $956.0M | $971.8M | ||
| Q2 25 | $654.8M | $961.9M | ||
| Q1 25 | $620.4M | $862.5M | ||
| Q4 24 | $665.2M | $944.2M | ||
| Q3 24 | $478.7M | $1.1B | ||
| Q2 24 | $486.3M | $1.1B | ||
| Q1 24 | $404.4M | $941.5M |
净利润ASTHCAPL
| Q4 25 | $6.6M | $10.2M | ||
| Q3 25 | $373.0K | $13.6M | ||
| Q2 25 | $9.4M | $25.2M | ||
| Q1 25 | $6.7M | $-7.1M | ||
| Q4 24 | $-7.8M | $16.9M | ||
| Q3 24 | $16.1M | $10.7M | ||
| Q2 24 | $19.2M | $12.4M | ||
| Q1 24 | $14.8M | $-17.5M |
毛利率ASTHCAPL
| Q4 25 | — | 12.4% | ||
| Q3 25 | — | 10.8% | ||
| Q2 25 | — | 10.5% | ||
| Q1 25 | — | 10.4% | ||
| Q4 24 | — | 10.7% | ||
| Q3 24 | — | 10.3% | ||
| Q2 24 | — | 9.2% | ||
| Q1 24 | — | 8.6% |
营业利润率ASTHCAPL
| Q4 25 | 1.9% | 3.0% | ||
| Q3 25 | 2.0% | 2.9% | ||
| Q2 25 | 3.1% | 4.3% | ||
| Q1 25 | 3.3% | 0.2% | ||
| Q4 24 | 0.1% | 3.0% | ||
| Q3 24 | 5.9% | 2.5% | ||
| Q2 24 | 6.2% | 2.5% | ||
| Q1 24 | 7.5% | -1.4% |
净利率ASTHCAPL
| Q4 25 | 0.7% | 1.2% | ||
| Q3 25 | 0.0% | 1.4% | ||
| Q2 25 | 1.4% | 2.6% | ||
| Q1 25 | 1.1% | -0.8% | ||
| Q4 24 | -1.2% | 1.8% | ||
| Q3 24 | 3.4% | 1.0% | ||
| Q2 24 | 3.9% | 1.1% | ||
| Q1 24 | 3.7% | -1.9% |
每股收益（稀释后）ASTHCAPL
| Q4 25 | $0.12 | $0.24 | ||
| Q3 25 | $0.01 | $0.34 | ||
| Q2 25 | $0.19 | $0.64 | ||
| Q1 25 | $0.14 | $-0.20 | ||
| Q4 24 | $-0.14 | $0.42 | ||
| Q3 24 | $0.33 | $0.27 | ||
| Q2 24 | $0.40 | $0.31 | ||
| Q1 24 | $0.31 | $-0.48 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $3.1M |
| 总债务越低越好 | — | $687.2M |
| 股东权益账面价值 | $779.3M | — |
| 总资产 | $2.2B | $964.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASTHCAPL
| Q4 25 | $429.5M | $3.1M | ||
| Q3 25 | $463.4M | $5.8M | ||
| Q2 25 | $342.1M | $9.7M | ||
| Q1 25 | $260.9M | $6.7M | ||
| Q4 24 | $290.8M | $3.4M | ||
| Q3 24 | $350.3M | $7.8M | ||
| Q2 24 | $327.7M | $5.5M | ||
| Q1 24 | $337.3M | $6.3M |
总债务ASTHCAPL
| Q4 25 | — | $687.2M | ||
| Q3 25 | — | $700.8M | ||
| Q2 25 | — | $722.7M | ||
| Q1 25 | — | $774.1M | ||
| Q4 24 | — | $763.9M | ||
| Q3 24 | — | $769.2M | ||
| Q2 24 | — | $786.7M | ||
| Q1 24 | — | $795.8M |
股东权益ASTHCAPL
| Q4 25 | $779.3M | — | ||
| Q3 25 | $775.5M | — | ||
| Q2 25 | $765.5M | — | ||
| Q1 25 | $745.4M | — | ||
| Q4 24 | $712.7M | — | ||
| Q3 24 | $704.6M | — | ||
| Q2 24 | $678.9M | — | ||
| Q1 24 | $653.5M | — |
总资产ASTHCAPL
| Q4 25 | $2.2B | $964.7M | ||
| Q3 25 | $2.2B | $998.9M | ||
| Q2 25 | $1.4B | $1.0B | ||
| Q1 25 | $1.3B | $1.1B | ||
| Q4 24 | $1.4B | $1.1B | ||
| Q3 24 | $1.3B | $1.1B | ||
| Q2 24 | $1.3B | $1.2B | ||
| Q1 24 | $1.2B | $1.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | $29.4M |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | $22.4M |
| 自由现金流率自由现金流/营收 | -0.6% | 2.6% |
| 资本支出强度资本支出/营收 | 0.3% | 0.8% |
| 现金转化率经营现金流/净利润 | -0.44× | 2.89× |
| 过去12个月自由现金流最近4个季度 | $104.5M | $55.8M |
8季度趋势，按日历期对齐
经营现金流ASTHCAPL
| Q4 25 | $-2.9M | $29.4M | ||
| Q3 25 | $10.0M | $24.4M | ||
| Q2 25 | $90.9M | $22.6M | ||
| Q1 25 | $16.6M | $15.0M | ||
| Q4 24 | $-10.9M | $11.1M | ||
| Q3 24 | $34.0M | $41.9M | ||
| Q2 24 | $23.2M | $28.9M | ||
| Q1 24 | $6.0M | $5.8M |
自由现金流ASTHCAPL
| Q4 25 | $-6.0M | $22.4M | ||
| Q3 25 | $7.4M | $17.7M | ||
| Q2 25 | $89.5M | $10.8M | ||
| Q1 25 | $13.6M | $4.9M | ||
| Q4 24 | $-13.5M | $3.9M | ||
| Q3 24 | $31.7M | $34.2M | ||
| Q2 24 | $20.4M | $23.6M | ||
| Q1 24 | $5.6M | $-289.0K |
自由现金流率ASTHCAPL
| Q4 25 | -0.6% | 2.6% | ||
| Q3 25 | 0.8% | 1.8% | ||
| Q2 25 | 13.7% | 1.1% | ||
| Q1 25 | 2.2% | 0.6% | ||
| Q4 24 | -2.0% | 0.4% | ||
| Q3 24 | 6.6% | 3.2% | ||
| Q2 24 | 4.2% | 2.1% | ||
| Q1 24 | 1.4% | -0.0% |
资本支出强度ASTHCAPL
| Q4 25 | 0.3% | 0.8% | ||
| Q3 25 | 0.3% | 0.7% | ||
| Q2 25 | 0.2% | 1.2% | ||
| Q1 25 | 0.5% | 1.2% | ||
| Q4 24 | 0.4% | 0.8% | ||
| Q3 24 | 0.5% | 0.7% | ||
| Q2 24 | 0.6% | 0.5% | ||
| Q1 24 | 0.1% | 0.6% |
现金转化率ASTHCAPL
| Q4 25 | -0.44× | 2.89× | ||
| Q3 25 | 26.69× | 1.79× | ||
| Q2 25 | 9.65× | 0.90× | ||
| Q1 25 | 2.48× | — | ||
| Q4 24 | — | 0.66× | ||
| Q3 24 | 2.11× | 3.92× | ||
| Q2 24 | 1.21× | 2.33× | ||
| Q1 24 | 0.40× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
CAPL
| Retail Segment | $505.3M | 58% |
| Wholesale | $360.9M | 42% |
| Other | $1.2M | 0% |
